These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic potential of brain natriuretic peptide (BNP) in predialysis chronic kidney disease patients. Carr SJ; Bavanandan S; Fentum B; Ng L Clin Sci (Lond); 2005 Jul; 109(1):75-82. PubMed ID: 15743271 [TBL] [Abstract][Full Text] [Related]
3. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients. Chazot C; Vo-Van C; Zaoui E; Vanel T; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Jean G Nephrol Dial Transplant; 2011 Aug; 26(8):2630-4. PubMed ID: 21273234 [TBL] [Abstract][Full Text] [Related]
4. Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients. Breidthardt T; Kalbermatter S; Socrates T; Noveanu M; Klima T; Mebazaa A; Mueller C; Kiss D Eur J Heart Fail; 2011 Aug; 13(8):860-7. PubMed ID: 21628312 [TBL] [Abstract][Full Text] [Related]
5. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220 [TBL] [Abstract][Full Text] [Related]
6. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up. Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease. Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308 [TBL] [Abstract][Full Text] [Related]
8. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242 [TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Detaint D; Messika-Zeitoun D; Avierinos JF; Scott C; Chen H; Burnett JC; Enriquez-Sarano M Circulation; 2005 May; 111(18):2391-7. PubMed ID: 15883225 [TBL] [Abstract][Full Text] [Related]
10. [Plasma B-type natriuretic peptide level predicts the renal outcome in patients with chronic kidney disease]. Yasuda K; Kimura T; Obi Y; Sasaki K; Hatanaka M; Isaka Y; Rakugi H; Hayashi T Nihon Jinzo Gakkai Shi; 2010; 52(8):1007-14. PubMed ID: 21254696 [TBL] [Abstract][Full Text] [Related]
11. NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure. Pfister R; Müller-Ehmsen J; Hagemeister J; Hellmich M; Erdmann E; Schneider CA Intern Med J; 2011 Jun; 41(6):467-72. PubMed ID: 20214692 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery. Goei D; van Kuijk JP; Flu WJ; Hoeks SE; Chonchol M; Verhagen HJ; Bax JJ; Poldermans D Am J Cardiol; 2011 Feb; 107(4):609-14. PubMed ID: 21185000 [TBL] [Abstract][Full Text] [Related]
13. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between B-type natriuretic peptide plasma level and left ventricular function in patients with chronic kidney disease on different type of treatment]. Rasić S; Hadzovic-Dzuvo A; Rebić D; Dzemidzić J; Bilal F; Mataradzija A Acta Med Croatica; 2008; 62 Suppl 1():7-11. PubMed ID: 18578326 [TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099 [TBL] [Abstract][Full Text] [Related]
16. Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration. Sivalingam M; Suresh M; Farrington K Hemodial Int; 2011 Jul; 15(3):359-65. PubMed ID: 21624043 [TBL] [Abstract][Full Text] [Related]
17. Prognostic values of NTpro BNP/BNP ratio in comparison with NTpro BNP or BNP alone in elderly patients with chronic heart failure in a 2-year follow up. Jensen J; Ma LP; Bjurman C; Hammarsten O; Fu ML Int J Cardiol; 2012 Feb; 155(1):1-5. PubMed ID: 21334085 [TBL] [Abstract][Full Text] [Related]
18. Circulating α-klotho levels in CKD and relationship to progression. Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260 [TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Post F; Weilemann LS; Messow CM; Sinning C; Münzel T Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Takami Y; Horio T; Iwashima Y; Takiuchi S; Kamide K; Yoshihara F; Nakamura S; Nakahama H; Inenaga T; Kangawa K; Kawano Y Am J Kidney Dis; 2004 Sep; 44(3):420-8. PubMed ID: 15332214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]